BioSpace News Archive

SPL Medical Announces First Prostate Cancer Metastasis Patient Diagnosed with Ferrotran® in Compassionate Use Program in Switzerland

Novel imaging agent allows detection of lymph node metastases at earlier stage, allowing more effective treatment

December 12, 2019
·
3 min read
Drug Development

Moberg Pharma Comments on the Results of the North American Phase 3 Study With MOB-015

Moberg Pharma AB : On Monday the topline results were presented from the first study in the Phase 3 program for MOB-015, where the primary endpoint and the two key secondary endpoints were met.

December 12, 2019
·
6 min read
Business

Iktos and Almirall Announce Research Collaboration in Artificial Intelligence for New Drug Design

Generative modelling artificial intelligence (AI) technology will be used to optimise advanced compounds, to speed up the identification of promising drug candidates for an undisclosed Almirall drug discovery program.

December 12, 2019
·
4 min read
BioCapital

Lung Cancer Registry Launches New Surveys

New Modules to Capture Longitudinal Data on Patients with Lung Cancer

December 12, 2019
·
2 min read
Cergentis launches TLA technology for complete cancer gene mutation sequencingTLA provides additional actionable genetic information from FFPE tumour samples

Cergentis announced the launch of TLA for complete cancer gene sequencing and reported superior data over conventional diagnostic and gene sequencing techniques in FFPE tumour samples.

December 12, 2019
·
2 min read
Drug Development

Nordic Nanovector Provides Update on LYMRIT 37-05 Phase 1 DLBCL Trial

Nordic Nanovector ASA reports an update on its LYMRIT 37-05 Phase 1 trial of Betalutin® in patients with relapsed/refractory diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation.

December 12, 2019
·
4 min read
Business

BIOCORP and SANOFI Announce a Partnership to Fit SoloStar Insulin Pens With Mallya Technology Worldwide

After an initial payment of €4 million, BIOCORP receives a new payment of €2 million upon signature, followed by additional milestone payments

December 12, 2019
·
3 min read
Emergex Completes First Step in the Development of a Vaccine Candidate Against Intracellular Bacterium and Bioterrorist Agent Francisella Tularensis

Emergex Vaccines Holding Limited announced it has successfully completed the first step in the development of a candidate vaccine for the Gram-negative intracellular coccobacillus, Francisella tularensis.

December 12, 2019
·
4 min read
Business

Walgreens Boots Alliance and McKesson to Create German Wholesale Joint Venture

New entity combines wholesale operations to drive sustainable growth and deliver efficient distribution solutions for an evolving market

December 12, 2019
·
5 min read
Drug Development

Gritstone Oncology Reports Promising Early Immunogenicity Activity and Safety Data from its Phase 1 Studies Evaluating its Neoantigen-based Immunotherapies, GRANITE and SLATE

Preliminary results demonstrate unprecedented levels of primed CD8+ neoantigen-specific cytotoxic T cells and expansion of pre-existing T cells even in low-dose cohorts

December 12, 2019
·
7 min read